Translating Anesthesia Care Throughout
TACT
Translating Anesthetic Care Throughout: A Feasibility Randomized Trial
1 other identifier
interventional
22
1 country
1
Brief Summary
Patients with limited English proficiency (LEP) are at significant risk of receiving care different from those who are English proficient. Through Translating Anesthetic Care Throughout (TACT), the investigators aim to reduce the disparities experienced by participants with LEP undergoing anesthesia by continuing language translation from the preoperative area into the operating room, where participants will be better able to understand what is happening in an otherwise foreign environment. At this time, some participants receive translation in the preoperative area using an interpreter. No further translation is provided beyond the preoperative area unless there is a provider with language concordance or interpretation skills within the perioperative team. The investigators plan to study how extended translation changes a participant's understanding of and feelings about the perioperative period. Supporting language translation for LEP participants from the preoperative area into their operating room (OR) experience will enable providers to better understand how to care for participants from different cultural and language backgrounds and will help us understand how to better serve our community at large. The investigators hypothesize that participants who receive continual translation will have improved informed consent, have improved trust of their anesthesia providers, and be more satisfied with patient care. In addition, they anticipate that the care team also will benefit by the enhanced communication with the participant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2022
CompletedFirst Posted
Study publicly available on registry
August 16, 2022
CompletedStudy Start
First participant enrolled
February 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2023
CompletedAugust 1, 2023
July 1, 2023
4 months
August 12, 2022
July 31, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Informed consent success as assessed by Likert scale
The participant will be asked how well their anesthesia provider prepared them for their general anesthesia experience. A 5-point Likert scale response will be used for the assessment ranging from 1 (not at all) to 5 (extremely well).
One week after general anesthesia
Participant trust as assessed by survey
Participants will be asked whether they trusted their provider(s) using a yes/no response.
One week after general anesthesia
Participant satisfaction as assessed by Likert scale
Participants will be asked whether they were satisfied with their anesthesia experience using a yes/no response.
One week after general anesthesia
Secondary Outcomes (1)
Participant anxiety as assessed by the Amsterdam Preoperative Anxiety and Information Scale
The day before surgery
Study Arms (2)
Control
ACTIVE COMPARATORTranslator in preoperative area
Intervention
EXPERIMENTALTranslator in preoperative area, continued through transport to the operating room, and in the operating room until the patient is under general anesthesia
Interventions
Eligibility Criteria
You may qualify if:
- Participants who identify another language other than English as their preferred language
- Participants with planned general anesthesia
You may not qualify if:
- Participants whose preferred language is documented as English
- Participants with planned sedation or monitored anesthesia care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Mount Zion Health Fundcollaborator
Study Sites (1)
UCSF Medical Center at Mount Zion
San Francisco, California, 94115, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Odmara Barreto Chang, MD, PhD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2022
First Posted
August 16, 2022
Study Start
February 14, 2023
Primary Completion
June 12, 2023
Study Completion
June 12, 2023
Last Updated
August 1, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share
This is a pilot study whose results are intended to inform the investigators of whether additional study is warranted.